Stock 6998 GENOR BIOPHARMA HOLDINGS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Genor Biopharma Holdings Limited Share Price

Equities

6998

KYG3871A1004

Biotechnology & Medical Research

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:35 13/05/2024 BST 		5-day change 1st Jan Change
1.42 HKD +1.43% Intraday chart for Genor Biopharma Holdings Limited +13.60% +19.33%
03-27 Genor Biopharma Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-14 China's Drug Regulator Accepts Genor Biopharma's New Breast Cancer Drug Application; Shares Up 7% MT

Financials

Sales 2021 - Sales 2022 15.93M 2.2M 17.2M 176M Capitalization 1.17B 162M 1.27B 12.94B
Net income 2021 -865M -120M -934M -9.55B Net income 2022 -730M -101M -788M -8.06B EV / Sales 2021 -
Net cash position 2021 2.14B 296M 2.31B 23.65B Net cash position 2022 1.56B 216M 1.68B 17.22B EV / Sales 2022 -24.3 x
P/E ratio 2021
-3.28 x
P/E ratio 2022
-1.62 x
Employees 104
Yield 2021 *
-
Yield 2022
-
Free-Float 66.07%
More Fundamentals * Assessed data

Chart Genor Biopharma Holdings Limited

Dynamic Chart

Latest news about Genor Biopharma Holdings Limited

Genor Biopharma Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI
China's Drug Regulator Accepts Genor Biopharma's New Breast Cancer Drug Application; Shares Up 7% MT
Genor Biopharma Holdings Limited Announces China National Medical Products Administration Accepts New Drug Application for GB491 CI
More news

Quotes and Performance

1 day+1.43%
1 week+13.60%
Current month+13.60%
1 month+18.33%
3 months+52.69%
6 months+2.16%
Current year+19.33%
More quotes

Highs and lows

1 week
1.16
Extreme 1.16
1.50
1 month
1.03
Extreme 1.03
1.50
Current year
0.85
Extreme 0.85
1.50
1 year
0.85
Extreme 0.85
1.99
3 years
0.85
Extreme 0.85
19.00
5 years
0.85
Extreme 0.85
32.20
10 years
0.85
Extreme 0.85
32.20
More quotes

Quotes

Date Price Change Volume
13/05/24 1.42 +1.43% 447 618
10/05/24 1.4 +0.72% 160,000
09/05/24 1.39 +4.51% 631,000
08/05/24 1.33 +7.26% 279,000
07/05/24 1.24 +5.98% 573,000

Delayed Quote Hong Kong S.E., May 13, 2024 at 09:08 am

More quotes

Company Profile

Genor Biopharma Holdings Ltd, formerly JHBP CY Holdings Ltd, is China-based company mainly engaged in the research and development of biopharmaceutical products. The Company focuses on the development and commercialization of oncology and autoimmune drugs. The Company's main drugs include lerociclib (GB491), coprelotamab (GB221), geptanolimab (GB226), GB492, GB242 and GB223. The Company mainly conducts its businesses in the China market.
Sector
Biotechnology & Medical Research
Calendar
27/08/2024 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Therapeutic Drugs

1st Jan change Capi.
GENOR BIOPHARMA HOLDINGS LIMITED Stock Genor Biopharma Holdings Limited
+19.33% 91.15M
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
+3.91% 109B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+10.87% 105B
ARGENX SE Stock argenx SE
+0.23% 22.25B
BIONTECH SE Stock BioNTech SE
-13.14% 22.09B
GENMAB A/S Stock Genmab A/S
-7.70% 18.68B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-38.36% 17.58B
BEIGENE, LTD. Stock BeiGene, Ltd.
-10.66% 16.85B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.75% 13.76B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+36.70% 12.46B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. 6998 Stock